Isolated Colon Cancer Metastasis to the Spleen

Place, Ronald J.
May 2001
American Surgeon;May2001, Vol. 67 Issue 5, p454
Academic Journal
Splenic metastases from colon carcinoma are rare. If present they generally occur in concert with disseminated disease. Six cases have been previously reported. The patient presented here is a 51-year-old black man who presented with an enterocutaneous fistula as a complication from prior pelvic radiation. Workup included an abdominal CT and needle biopsy, which confirmed the splenic metastasis from a sigmoid colon cancer 6 years after the original diagnosis. The patient had an unevenful splenectomy. Although no long-term follow-up data are as yet available splenectomy including removal of hilar lymph nodes appears to be the treatment of choice. A case report and review of the literature are presented.


Related Articles

  • Isolated Splenic Metastasis from Colon Cancer -- Case Report and Literature Review. Bušić, Željko; Čupurdija, Kristijan; Kolovrat, Marijan; Ćavka, Vlatka; Čavka, Mislav; Patrlj, Leonardo; Servis, Dražen; Kvesić, Ante // Collegium Antropologicum;2010 Supplement 1, Vol. 34, p287 

    Solitary splenic metastases are very rare and sporadic. There are several explanations for this low incidence of splenic metastasis including anatomical, histological and immunological features of the spleen. In this paper we present a case of 70-year-old man with no history of previous diseases...

  • An unusual site of metastasis: splenic metastastasis from a colon cancer. Efared, Boubacar; Mazti, Asmae; Atsame-Ebang, Gabrielle; Tahiri, Layla; El Bouhaddouti, Hicham; Hammas, Nawal; El Fatemi, Hind; Chbani, Laila // Journal of Surgical Case Reports;Nov2016, Vol. 2016 Issue 11, p1 

    Splenic metastasis from colorectal cancers is a very rare occurrence. Few cases have been reported in the literature. We report herein an additionnal case of metachronous splenic metastasis from adenocarcinoma of the sigmoid colon, 3 years after the diagnosis of the primary tumor. A 62-year old...

  • Increased local cytostatic drug exposure by isolated hepatic perfusion: a phase I clinical and pharmacologic evaluation of treatment with high dose melphalan in patients with colorectal cancer confined to the liver. Vahrmeijer, A L; van Dierendonck, J H; Keizer, H J; Beijnen, J H; Tollenaar, R A E M; Pijl, M E J; Marinelli, A; Kuppen, P J K; van Bockel, J H; Mulder, G J; Velde, C J H van de // British Journal of Cancer;5/1/2000, Vol. 82 Issue 9, p1539 

    A phase I dose-escalation study was performed to determine whether isolated hepatic perfusion (IHP) with melphalan (L-PAM) allows exposure of the liver to much higher drug concentrations than clinically achievable after systemic administration and leads to higher tumour concentrations of L-PAM....

  • Increased expression of S100A6 at the invading fronts of the primary lesion and liver metastasis in patients with colorectal adenocarcinoma. Komatsu, K; Kobune-Fujiwara, Y; Andoh, A; Ishiguro, S; Hunai, H; Suzuki, N; Kameyama, M; Murata, K; Miyoshi, J; Akedo, H; Tatsuta, M; Nakamura, H // British Journal of Cancer;9/15/2000, Vol. 83 Issue 6, p769 

    Two members of the S100 gene family, S100A6 and S100A4 have been suggested to be associated with cancer invasion and metastasis. To study their involvement in the malignancy of human colorectal adenocarcinoma, we examined the protein expression levels of S100A6 and S100A4 in the primary...

  • Isolated Splenic Metastasis of Sigmoid Colon Cancer: a Case Report. Okuyama, Takashi // Japanese Journal of Clinical Oncology;Jul2001, Vol. 31 Issue 7, p341 

    Examines the isolated splenic metastasis of sigmoid colon cancer. Difference in progenitor cells between splenic metastasis and lymph node metastasis; Microenvironment of cancer cells between the spleen and lymph nodes; Evaluation of abdominal CT scans and abdominal ultrasonography following...

  • Atypical Bone Metastasis and Radiation Changes in a Colon Cancer: a Case Report and a Review of the Literature. Oh, Yoon Kyeong; Park, Hee Chul; Kim, Young Sook // Japanese Journal of Clinical Oncology;Apr2001, Vol. 31 Issue 4, p168 

    We report a unique case of skeletal metastasis with prominent soft tissue extension from a colon cancer in a 44-year-old male patient. Four years after the diagnosis of colon cancer, plain radiographic examinations revealed a prominent soft tissue mass associated with cortical destruction of the...

  • Ziv-aflibercept yields encouraging results in metastatic colorectal cancer.  // Hem/Onc Today;11/10/2012, Vol. 13 Issue 21, p26 

    The article reports on a study by Doctor Eric Van Cutsem, head of digestive oncology and professor of medicine at University Hospital Gasthuisberg in Leuven, Belgium, stating that the addition of ziv-aflibercept to infusional FOLFIRI improved survival in metastatic colorectal cancer patients.

  • Comment on "Clinical features and course of brain metastases in colorectal cancer: an experience from a single institution". Bernardi, D.; Tomassi, O.; Stefani, M.; Di Giacobbe, A.; Oncologia, U. O. // Current Oncology;Jun2013, Vol. 20 Issue 3, pe278 

    A letter to the editor is presented in response to the article "Clinical Features and Course of Brain Metastases in Colorectal Cancer: An Experience From a Single Institution" in 2012 issue.

  • Response to Bernardi and colleagues. Tehfe, Mustapha // Current Oncology;Jun2013, Vol. 20 Issue 3, pe279 

    A response from the author of the article "Clinical Features and Course of Brain Metastases in Colorectal Cancer: An Experience From a Single Institution" in the June 2011 issue is presented.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics